Intraosseous Vancomycin in Total Hip Arthroplasty - Superior Tissue Concentrations and Improved Efficiency.

[1]  S. Incavo,et al.  2021 Chitranjan S. Ranawat Award: Intraosseous vancomycin reduces periprosthetic joint infection in primary total knee arthroplasty at 90-day follow-up. , 2021, The bone & joint journal.

[2]  J. Bosco,et al.  Incomplete Administration of Intravenous Vancomycin Prophylaxis is Common and Associated With Increased Infectious Complications After Primary Total Hip and Knee Arthroplasty. , 2021, The Journal of arthroplasty.

[3]  S. Incavo,et al.  Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty , 2020, Arthroplasty today.

[4]  J. Singh,et al.  Acute kidney injury after primary total hip arthroplasty: a risk multiplier for complication, mortality, and healthcare utilization , 2020, Arthritis Research & Therapy.

[5]  Antonia F. Chen,et al.  Reducing the risk of infection after total joint arthroplasty: preoperative optimization , 2019, Arthroplasty.

[6]  J. Zuckerman,et al.  2019 Frank Stinchfield Award: A comparison of prosthetic joint infection rates between direct anterior and non-anterior approach total hip arthroplasty. , 2019, The bone & joint journal.

[7]  M. Bostrom,et al.  The Influence of Spacer Design on the Rate of Complications in Two-Stage Revision Hip Arthroplasty. , 2019, The Journal of arthroplasty.

[8]  S. Young,et al.  The AAHKS Clinical Research Award: Intraosseous Regional Prophylaxis Provides Higher Tissue Concentrations in High BMI Patients in Total Knee Arthroplasty: A Randomized Trial. , 2018, The Journal of arthroplasty.

[9]  H. Schønheyder,et al.  One-year incidence of prosthetic joint infection in total hip arthroplasty: a cohort study with linkage of the Danish Hip Arthroplasty Register and Danish Microbiology Databases. , 2017, Osteoarthritis and cartilage.

[10]  J. Parvizi,et al.  Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin , 2017, Clinical orthopaedics and related research.

[11]  Gwo-Chin Lee,et al.  Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty , 2015, Clinical orthopaedics and related research.

[12]  A. Larsson,et al.  Intraosseous and intravenous administration of antibiotics yields comparable plasma concentrations during experimental septic shock , 2015, Acta anaesthesiologica Scandinavica.

[13]  P. Wretenberg,et al.  Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register , 2014, BMC Musculoskeletal Disorders.

[14]  P. Pavlou,et al.  The Mark Coventry Award: Higher Tissue Concentrations of Vancomycin With Low-dose Intraosseous Regional Versus Systemic Prophylaxis in TKA , 2014, Clinical orthopaedics and related research.

[15]  D. Biau,et al.  Monitoring the one year postoperative infection rate after primary total hip replacement , 2012, International Orthopaedics.

[16]  J. Kelm,et al.  Mechanical complications and reconstruction strategies at the site of hip spacer implantation , 2009, International journal of medical sciences.

[17]  D. T. Bearden,et al.  Antimicrobial Dosing Considerations in Obese Adult Patients , 2007, Pharmacotherapy.

[18]  S. Francom,et al.  Evaluation of intraosseous vs intravenous antibiotic levels in a porcine model. , 1991, American journal of diseases of children.

[19]  J. Meehan,et al.  Mortality During Total Hip Periprosthetic Joint Infection. , 2019, The Journal of arthroplasty.

[20]  E. Yusuf,et al.  Vancomycin prophylaxis in prosthetic joint surgery? , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.